Abstract: The invention provides methods of modulating an immune system in a vertebrate host for the therapeutic or prophylactic treatment of infection by a first microbial pathogen in a target tissue, comprising administration at an administration site of an effective amount of an antigenic formulation comprising antigenic determinants specific for a second heterologous microbial pathogen.
Type:
Grant
Filed:
January 31, 2019
Date of Patent:
March 16, 2021
Assignee:
Qu Biologies Inc.
Inventors:
Harold David Gunn, Salim Dhanji, David W. Mullins